Welcome to the Week in Review.

1. Urgent Need for Drug Negotiations

2. New Bipartisan Legislation Targets Patent Thickets

3. Debunking Pharma’s Claims

BONUS: Senate Democrats, led by Sen. Bernie Sanders, are investigating soaring asthma inhaler costs. The probe addresses the stark U.S. price disparities, emphasizing concerns for patients who often face high costs and rationing. The inhalers sell for hundreds of dollars in the U.S. but much less abroad. (The Hill)